Medical aesthetic products. Croda acquires Solus Biotech to expand actives business in Asia
THE WHAT? Croda has announced that it has agreed to acquire Solus Biotech from Solus Advanced Materials for KRW350 billion on a debt-free, cash-free basis. Read More